Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. (2019)

First Author: Parker WAE
Attributed to:  Advancing early stage healthcare research in Sheffield funded by UKRI

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/09537104.2019.1572880

PubMed Identifier: 30759035

Publication URI: http://europepmc.org/abstract/MED/30759035

Type: Journal Article/Review

Volume: 30

Parent Publication: Platelets

Issue: 2

ISSN: 0953-7104